Company Encyclopedia
View More
name
Radnet
RDNT.US
RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States and internationally. The company operates in two segments, Imaging Centers and Digital Health. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretation of breast, lung, and prostate images, as well as solutions for prostate cancer screening.
385.97 B
RDNT.USMarket value -Rank by Market Cap -/-

Financial Score

27/12/2025 Update
C
Health Care ServicesIndustry
Industry Ranking29/82
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreD
    • ROE-1.30%D
    • Profit Margin-0.65%D
    • Gross Margin20.53%D
  • Growth ScoreC
    • Revenue YoY11.09%B
    • Net Profit YoY-188.08%E
    • Total Assets YoY11.91%B
    • Net Assets YoY17.36%A
  • Cash ScoreD
    • Cash Flow Margin-15496.45%E
    • OCF YoY11.09%B
  • Operating ScoreB
    • Turnover0.57B
  • Debt ScoreD
    • Gearing Ratio64.15%D

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    RadNet’s Strategic Growth and AI Success Justify Buy Rating Despite Concerns

    Raymond James analyst John Ransom maintains a Buy rating on RadNet (RDNT) stock, citing strategic growth and AI success. Despite concerns, RadNet's consolidation of facilities and effective cost management are highlighted. Imaging center revenue and EBITDA growth are projected at 10% and 11%, respectively. Ransom emphasizes RadNet's AI success in breast cancer detection and expects stock compensation to normalize. B. Riley Securities also reiterates a Buy rating with an $87.00 price target.

    Tip Ranks·
    US
    RDNT
    +0.29%
    Tip Ranks·
    US
    RDNT
    +0.29%

    RadNet (NASDAQ:RDNT) Shares Gap Down - Should You Sell?

    RadNet, Inc. (NASDAQ:RDNT) shares dropped from $72.58 to $65.78 before the market opened on Tuesday, closing at $67.29. Analysts have mixed ratings: B. Riley, Barclays, and Truist Financial gave 'buy' ratings with higher price targets, while Weiss Ratings issued a 'sell' rating. RadNet reported Q3 earnings of $0.20 per share, missing estimates. Insiders sold 50,000 shares recently. Institutional investors hold 77.90% of the stock. RadNet provides outpatient diagnostic imaging services in the U.S.

    Market Beat·
    US
    RDNT
    +0.29%
    Market Beat·
    US
    RDNT
    +0.29%

    RadNet Stock Hit By Short Seller Report, Questions AI Hype, Growth Claims

    RadNet shares fell after a short report by Hunterbrook Capital questioned its AI-driven valuation, low digital health revenue, and growth claims. The report highlighted that RadNet's AI rebrand led to a significant stock price increase, despite AI contributing less than 5% of revenue. It also alleged that RadNet's growth is mainly internal and that its core business remains low-margin. RadNet's recent earnings missed expectations, and the stock was down 7.40% at $67.21.

    benzinga_article·
    US
    RDNT
    +0.29%
    benzinga_article·
    US
    RDNT
    +0.29%

    RadNet shares are trading lower after Hunterbrook Capital announced a short position.

    benzinga_article·
    US
    RDNT
    +0.29%
    benzinga_article·
    US
    RDNT
    +0.29%

    Hilton Capital Management LLC Buys 19,285 Shares of RadNet, Inc. $RDNT

    Hilton Capital Management LLC increased its stake in RadNet, Inc. by 53% in Q2, owning 55,672 shares valued at $3,168,000. Other institutional investors also adjusted their positions. RadNet's stock opened at $73.94, with a market cap of $5.70 billion. Recent earnings missed estimates, but revenue rose 13.4% year-over-year. Insider sales and analyst ratings updates were also noted.

    Market Beat·
    US
    RDNT
    +0.29%
    Market Beat·
    US
    RDNT
    +0.29%
    Posts
    View More
    © 2025 Longbridge｜Disclaimer